logo
  • About
    • AWI Leadership Board
  • Resources by Tumor Type
  • Provider Resources
    • Care Step Pathways
    • Continuing Education
    • Provider Toolkits
    • JADPRO AIM with Immunotherapy Supplement
    • JCO OP AIM with Immunotherapy Supplement
    • Facebook Provider Community
    • News
  • Patient Resources
    • Patient Action Plans
    • Options for Stage III Melanoma
  • International Resources
    • Australia
    • Canada
    • France
    • Germany
    • Italy
    • Portugal
    • Spain
    • UK
  • Videos
    • HCP Videos
    • Patient Videos
  • Contact
  • About
    • AWI Leadership Board
  • Resources by Tumor Type
  • Provider Resources
    • Care Step Pathways
    • Continuing Education
    • Provider Toolkits
    • JADPRO AIM with Immunotherapy Supplement
    • JCO OP AIM with Immunotherapy Supplement
    • Facebook Provider Community
    • News
  • Patient Resources
    • Patient Action Plans
    • Options for Stage III Melanoma
  • International Resources
    • Australia
    • Canada
    • France
    • Germany
    • Italy
    • Portugal
    • Spain
    • UK
  • Videos
    • HCP Videos
    • Patient Videos
  • Contact
  • Profile
  • Topics Started
  • Replies Created
  • Engagements
  • Favorites

@kathleen-m-madden

Profile

Registered: 3 years, 3 months ago


Forums

Topics Started: 0

Replies Created: 0

Forum Role: Moderator

Login

Log In
Register Lost Password

Latest Activity

  • New BRAF/MEK inhibitors coming to market
    topic by Lisa Kottschade
    March 1
    in Dosing and administration
  • Adjuvant Immunotherapy in stage IIIA patients
    topic by Lisa Kottschade
    March 1
    in Expectations for therapy
  • Influenza and Tamiflu and Immunotherapy
    reply by Kathleen Madden
    February 25
    in Other
  • ASCO/NCCN guidlines now out
    reply by Mollie Reed
    February 23
    in Side-effect management
  • hepatotoxicity
    reply by Mollie Reed
    February 23
    in Side-effect management
© 2021 AIM with Immunotherapy. All rights reserved.
  • Terms
  • Privacy